The antiandrogen withdrawal syndrome (AAWS) is characterized by tumour regression on treatment discontinuation. Here, the mechanisms of AAWS and the development of treatment resistance are described, and the implications for the development of novel drugs and the challenges associated with redefining the utility of older treatments are discussed.
- David Lorente
- Joaquin Mateo
- Johann S. de Bono
